Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...
we assigned in a 1:1 ratio patients with resectable esophageal adenocarcinoma to receive perioperative chemotherapy with FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) plus surgery or ...
Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...
Background and Aim: Barrett's esophagus has been associated with the presence of hiatal hernia; however, to date no meta-analysis of the relationship has been performed. We aimed to conduct a ...
HealthDay on MSN13d
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal CancerHealthDay News — For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared ...
Gastroesophageal reflux disease, or GERD ... For those who can't, however, major surgery used to be the only option. Now, there's an incision-free option called transoral incisionless ...
The good news was a treatment plan that consisted of six weeks of intensive chemotherapy and radiation, followed by surgery that takes out two-thirds of the esophagus and one-third of the stomach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results